SPRB CIK: 1683553

Spruce Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.1
FY22:
−47.3
FY23:
−52.0
FY24:
−56.2
FY25:
−36.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−41.9
FY22:
−45.7
FY23:
−47.4
FY24:
−52.7
FY25:
−35.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.3
FY22:
−46.2
FY23:
−47.9
FY24:
−53.0
FY25:
−39.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.3
FY22:
−46.2
FY23:
−47.9
FY24:
−53.0
FY25:
−39.0

All amounts in millions USD Data sources:SEC EDGARTwelve Data